Transcatheter cardiac interventions in neonates with congenital heart disease: A single centre experience

Asli Nuriye Melekoglu, Osman Baspinar, Asli Nuriye Melekoglu, Osman Baspinar

Abstract

Objective: Percutaneous cardiac catheterization has been used as a diagnostic tool and as a therapeutic option in neonates with congenital heart disease (CHD). This study aimed to evaluate the procedural and short-term follow-up data of newborns who underwent cardiac catheterization procedures.

Methods: This retrospective study reviewed demographic, diagnostic and clinical data from the medical records of newborns who underwent percutaneous transcatheter interventions to treat CHD.

Results: Forty-six newborns were included in the study. The median gestational week and weight were 35.0 weeks and 2723 g, respectively. The median time to the procedure was 7.6 days. Aortic and pulmonary balloon valvuloplasty, ductal stenting, atrial balloon/blade septostomy and coronary fistula embolization procedures were used. The overall success rate was 73.9% (34 of 46 patients) with a complication rate of 28.3% (13 of 46 patients). Eleven patients (23.9%) underwent reinterventions after initial catheterization. Five patients (10.9%) died in the first 48 h after their procedures.

Conclusions: Interventional cardiological procedures applied during the neonatal period provide alternative life-saving methods to surgery, especially in developing countries where surgical outcomes are poor and newborn mortality rates are high.

Keywords: Cardiac catheterization; congenital heart disease; ductal stenting; newborn.

References

    1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–1900.
    1. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? where? why? Lancet 2005; 365: 891–900.
    1. Changlani TD, Jose A, Sudhakar A, et al. Outcomes of infants with prenatally diagnosed congenital heart disease delivered in a tertiary-care pediatric cardiac facility. Indian Pediatr 2015; 52: 852–856.
    1. Pruetz JD, Carroll C, Trento LU, et al. Outcomes of critical congenital heart disease requiring emergent neonatal cardiac intervention. Prenat Diagn 2014; 34: 1127–1132.
    1. Mellander M. Diagnosis and management of life-threating cardiac malformations in the newborn. Semin Fetal Neonatal Med 2013; 18: 302–310.
    1. Colaco SM, Karande T, Bobhate PR, et al. Neonates with critical congenital heart defects: Impact of fetal diagnosis on immediate and short-term outcomes. Ann Pediatr Cardiol 2017; 10: 126–130.
    1. Dorfman AT, Marino BS, Wernovsky G, et al. Critical heart disease in the neonate: Presentation and outcome at a tertiary care center. Pediatr Crit Care Med 2008; 9: 193–202.
    1. Rahkonen OP, Lee KJ, Chaturvedi RC, et al. The First Ten of Everything: A review of past and current practice in pediatric cardiac percutaneous interventions. Congenit Heart Dis 2015; 10: 292–301.
    1. Alsawah GA, Hafez MM, Matter M, et al. Balloon valvuloplasty for critical pulmonary valve stenosis in newborn: a single center ten-year experience. Prog Pediatr Cardiol 2016; 43: 127–131.
    1. Dancea A, Justino H, Martucci G. Catheter intervention for congenital heart disease at risk of circulatory failure. Can J Cardiol 2013; 29: 786–795.
    1. Lizano Santamaria RW, Gillespie MJ, Dori Y, et al. Palliative balloon pulmonary valvuloplasty for infants with unrestrictive ventricular septal defect or single ventricle associated with severe pulmonary stenosis. Catheter Cardiovasc Interv 2015; 86: 829–833.
    1. Celebi A, Yucel IK, Bulut MO, et al. Stenting of the ductus arteriosus in infants with functionally univentricular heart disease and ductal-dependent pulmonary blood flow: A single-center experience. Catheter Cardiovasc Interv 2017; 89: 699–708.
    1. Odemis E, Ozyilmaz I, Guzeltas A, et al. Transcatheter management of neonates with pulmonary atresia with intact ventricular septum: a single center experience from Turkey. Artif Organs 2013; 37: E56–E61.
    1. Bentham JR, Thomson JD. Current state of interventional cardiology in congenital heart disease. Arch Dis Child 2015; 100: 787–792.
    1. Yucel IK, Bulut MO, Kucuk M, et al. Intervention in patients with critical pulmonary stenosis in the ductal stenting era. Pediatr Cardiol 2016; 37: 1037–1045.
    1. Harris KC, Du W, Cowley CG, et al. A prospective observational multicenter study of balloon angioplasty for the treatment of native and recurrent coarctation of the aorta. Catheter Cardiovasc Interv 2014; 83: 1116–1123.
    1. Torres A, Vincent JA, Everett A, et al. Balloon valvuloplasty for congenital aortic stenosis: multi-center safety and efficacy outcome assessment. Catheter Cardiovasc Interv 2015; 86: 808–820.
    1. Rao PS. Should balloon angioplasty be used instead of surgery for native aortic coarctation? Br Heart J 1995; 74: 578–579.
    1. Sen S, Garg S, Rao SG, et al. Native aortic coarctation in neonates and infants: Immediate and midterm outcomes with balloon angioplasty and surgery. Ann Pediatr Cardiol 2018; 11: 261–266.
    1. Hu ZP, Wang ZW, Dai XF, et al. Outcomes of surgical versus balloon angioplasty treatment for native coarctation of the aorta: a meta-analysis. Ann Vasc Surg 2014; 28: 394–403.
    1. McMullan DM, Permut LC, Jones TK, et al. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow. J Thorac Cardiovasc Surg 2014; 147: 397–401.
    1. Thakkar B, Raval A, Madan T, et al. Transvenous arterial duct stenting in cyanotic patients with pulmonary atresia and ventricular septal defect. Prog Pediatr Cardiol 2016; 43: 119–126.
    1. Schranz D, Michel-Behnke I. Advances in interventional and hybrid therapy in neonatal congenital heart disease. Semin Fetal Neonatal Med 2013; 18: 311–321.
    1. Odemis E, Haydin S, Guzeltas A, et al. Stent implantation in the arterial duct of the newborn with duct-dependent pulmonary circulation: single centre experience from Turkey. Eur J Cardiothorac Surg 2012; 42: 57–60.
    1. Mallula K, Vaughn G, El-Said H, et al. Comparison of ductal stenting versus surgical shunts for palliation of patients with pulmonary atresia and intact ventricular septum. Catheter Cardiovasc Interv 2015, 85: 1196–1202.
    1. Karagöz T, Akın A, Aykan HH, et al. Interventional cardiac catheterization in infants weighing less than 2500 g. Turk J Pediatr 2015; 57: 136–140.
    1. Vitiello R, McCrindle BW, Nykanen D, et al. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998; 32: 1433–1440.
    1. Larsen SH, Emmertsen K, Hjortdal VE, et al. Adverse events in transcatheter interventions for congenital heart disease: a population-based long-term study. Congenit Heart Dis 2015; 10: 153–158.
    1. Rao PS, Chopra PS, Koscik R, et al. Surgical versus balloon therapy for aortic coarctation in infants < or = 3 months old. J Am Coll Cardiol 1994; 23: 1479–1483.
    1. Benavidez OJ, Gauvreau K, Del Nido P, et al. Complications and risk factors for mortality during congenital heart surgery admissions. Ann Thorac Surg 2007; 84: 147–155.
    1. Phillips BL, Cabalka AK, Hagler DJ, et al. Procedural complications during congenital cardiac catheterisation. Congenit Heart Dis 2010; 5: 118–123.
    1. Bové T, Francois K, De Groote K, et al. Outcome analysis of major cardiac operations in low weight neonates. Ann Thorac Surg 2004; 78: 181–187.
    1. Alsoufi B, Manlhiot C, Mahle WT, et al. Low-weight infants are at increased mortality risk after palliative or corrective cardiac surgery. J Thorac Cardiovasc Surg 2014; 148: 2508–2514.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する